Patients at Salford Royal will help accelerate development of a diagnostic test for early detection of colorectal cancer. Dr Arash Assadsangabi will lead collection of samples via the NCARC tissue bank to evaluate Tagomics’ novel test in real-world samples. www.ncaresearch.org.uk/news/could-w...
September 16, 2025 at 5:31 PM
Patients at Salford Royal will help accelerate development of a diagnostic test for early detection of colorectal cancer. Dr Arash Assadsangabi will lead collection of samples via the NCARC tissue bank to evaluate Tagomics’ novel test in real-world samples. www.ncaresearch.org.uk/news/could-w...
Biomarker discovery and diagnostics company Tagomics has been awarded £860,000 Innovate UK funding as part of the Biomedical Catalyst programme for the testing and development of innovative healthcare solutions.
healthcaretoday.com/article/tago...
#healthcare #investment #biotechnology #innovation
healthcaretoday.com/article/tago...
#healthcare #investment #biotechnology #innovation
Tagomics awarded grant to detect colorectal cancer
The Cambridge-based biomarker discovery and diagnostics company has been awarded funding as part of the Biomedical Catalyst programme.
healthcaretoday.com
June 26, 2025 at 8:47 AM
Biomarker discovery and diagnostics company Tagomics has been awarded £860,000 Innovate UK funding as part of the Biomedical Catalyst programme for the testing and development of innovative healthcare solutions.
healthcaretoday.com/article/tago...
#healthcare #investment #biotechnology #innovation
healthcaretoday.com/article/tago...
#healthcare #investment #biotechnology #innovation
Today, Tagomics has introduced LiquiPath, its cfDNA-based blood test for multi-organ drug safety monitoring, giving drug developers earlier and clearer insights into patient safety.
Read more on Tagomics’ new website: tinyurl.com/393bjenv
Read more on Tagomics’ new website: tinyurl.com/393bjenv
August 17, 2026 at 8:56 AM
Today, Tagomics has introduced LiquiPath, its cfDNA-based blood test for multi-organ drug safety monitoring, giving drug developers earlier and clearer insights into patient safety.
Read more on Tagomics’ new website: tinyurl.com/393bjenv
Read more on Tagomics’ new website: tinyurl.com/393bjenv
Tagomics published a peer-reviewed study in Cell Reports Methods, underpinning its epigenomic profiling technology, Active-Seq, the basis of Tagomics’ ActivaceTM platform
➡️ bit.ly/4nmE2FU
➡️ bit.ly/4nmE2FU
September 30, 2025 at 3:33 PM
Tagomics published a peer-reviewed study in Cell Reports Methods, underpinning its epigenomic profiling technology, Active-Seq, the basis of Tagomics’ ActivaceTM platform
➡️ bit.ly/4nmE2FU
➡️ bit.ly/4nmE2FU
This week, Tagomics has been awarded £860k
@innovateuk.bsky.social funding as part of the Biomedical Catalyst grant for a £1.2M project to customise its multiomic profiling platform, Interlace, for the early detection of colorectal cancer.
Read more: tagomics.com/tagomics-awa...
@innovateuk.bsky.social funding as part of the Biomedical Catalyst grant for a £1.2M project to customise its multiomic profiling platform, Interlace, for the early detection of colorectal cancer.
Read more: tagomics.com/tagomics-awa...
June 12, 2025 at 12:35 PM
This week, Tagomics has been awarded £860k
@innovateuk.bsky.social funding as part of the Biomedical Catalyst grant for a £1.2M project to customise its multiomic profiling platform, Interlace, for the early detection of colorectal cancer.
Read more: tagomics.com/tagomics-awa...
@innovateuk.bsky.social funding as part of the Biomedical Catalyst grant for a £1.2M project to customise its multiomic profiling platform, Interlace, for the early detection of colorectal cancer.
Read more: tagomics.com/tagomics-awa...
#diagnostics #colorectalcancer #Tagomics #colorectalcancertest #Biotech #NHS #InnovateUK #BiomedicalCatalystprogramme #Interlaceplatform #biomarkers #epigeneticmarkers #epigeneticprofiling #multiomicworkflow #AgilentTechnologies #SureSelect #multiomicprofiling
pharmatimes.com/news/tagomic...
pharmatimes.com/news/tagomic...
Tagomics secures £860k grant for colorectal cancer test - PharmaTimes
Biotech firm to collaborate with NHS on early detection study
pharmatimes.com
June 11, 2025 at 8:27 AM
Feed: "Medical Device Network"
By: Ross Law on Tuesday, June 10, 2025
By: Ross Law on Tuesday, June 10, 2025
Tagomics awarded £860k grant for colorectal cancer diagnostic
Tagomics has been awarded £860,000 ($1.1m) from Innovate UK to develop a test for diagnosing early-stage colorectal cancer (CRC).
www.medicaldevice-network.com
June 11, 2025 at 6:49 PM
Feed: "Medical Device Network"
By: Ross Law on Tuesday, June 10, 2025
By: Ross Law on Tuesday, June 10, 2025
Feed: "PharmaTimes"
By: John Pinching on Tuesday, June 10, 2025
By: John Pinching on Tuesday, June 10, 2025
Tagomics secures £860k grant for colorectal cancer test
Biotech firm to collaborate with NHS on early detection study
pharmatimes.com
June 10, 2025 at 10:52 AM
Feed: "PharmaTimes"
By: John Pinching on Tuesday, June 10, 2025
By: John Pinching on Tuesday, June 10, 2025
#A Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025
https://www.stocktitan.net/news/A/agilent-showcases-solutions-and-partnerships-transforming-cancer-ydhx0ye43yrv.html
https://www.stocktitan.net/news/A/agilent-showcases-solutions-and-partnerships-transforming-cancer-ydhx0ye43yrv.html
Agilent's New 5-Hour Cancer DNA Test Breakthrough: Major Partnerships Reshape Cancer Diagnostics
Revolutionary 5-hour cancer detection workflow unveiled, alongside strategic partnerships with Abcam, Tagomics, and Roswell Park. Access exclusive details.
www.stocktitan.net
April 24, 2025 at 12:00 PM
#A Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025
https://www.stocktitan.net/news/A/agilent-showcases-solutions-and-partnerships-transforming-cancer-ydhx0ye43yrv.html
https://www.stocktitan.net/news/A/agilent-showcases-solutions-and-partnerships-transforming-cancer-ydhx0ye43yrv.html
